Saliladja, Sabriya T.

HRN: 23-34-10  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
04/07/2024
04/13/2024
IVT
4ml
TID
Age With Mod DHN
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: